Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rosliv
- Development stage
- Unknown
- Lead developer
- Yodley Life Sciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Rosliv is a veterinary liver tonic and nutritional supplement developed by Rosetta Lifecare. It is formulated as a syrup intended for use in livestock, poultry, and pets to support hepatic function and overall metabolic health. As a finished generic veterinary formulation, it typically contains a combination of vitamins, amino acids, and hepatoprotective agents designed to aid in liver detoxification, stimulate appetite, and promote recovery from hepatic stress or injury. The product is marketed as part of a broader portfolio of commercial veterinary pharmaceuticals including boluses, liquids, and tablets.
- Brand names
- RoslivROSLIV Syrup
02
Targets
HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)
Beyond the preview
Go deeper on Rosliv.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rosliv.